| Name: | Dabigatran Etexilate Mesylate Impurity B |
| Catalogue No. | VE006259 |
| CAS No. | N/A |
| Molecular Formula | C27H26N6O3 |
| Molecular Weight | 482.55 |
| Status | In-stock |
| IUPAC Name | ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate |
| Description | Dabigatran Etexilate Mesylate Impurity B or ethyl 3-(2-(((4-cyanophenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoate is a potential impurity of Dabigatran. Dabigatran is a direct thrombin inhibitor and evaluated extensively as an anticoagulant for the prevention of stroke in patients with atrial fibrillation. |
| References | Schiele, Felix, et al. “A Specific Antidote for Dabigatran: Functional and Structural Characterization.” Blood, vol. 121, no. 18, May 2013, pp. 3554–62,https://doi.org/10.1182/blood-2012-11-468207. |
